BioVie Inc.
BIVI
$7.14
-$0.43-5.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 47.66% | 43.90% | 49.43% | 36.09% | 26.29% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -96.88% | 438.26% | 464.40% | 419.03% | 434.35% |
| Total Other Non-Cash Items | 596.56% | 81.76% | -66.31% | -68.11% | -95.17% |
| Change in Net Operating Assets | -293.53% | -1,977.08% | 230.42% | 67.86% | -119.73% |
| Cash from Operations | 50.54% | 46.43% | 55.22% | 30.58% | -1.14% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | -100.00% | 201.57% | 201.79% |
| Cash from Investing | -100.00% | -100.00% | -100.00% | 201.57% | 201.79% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.33% | -117.00% | -300.00% | -- | -- |
| Issuance of Common Stock | -36.10% | 81.94% | -38.08% | -49.79% | -46.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -52.59% | 70.53% | -57.75% | -67.85% | -60.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -677.44% | 116.37% | -7,253.70% | 435.02% | -113.68% |